摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-phenylpiperazin-1-ylmethyl)indole-3-carbaldehyde oxime | 459448-42-1

中文名称
——
中文别名
——
英文名称
2-(4-phenylpiperazin-1-ylmethyl)indole-3-carbaldehyde oxime
英文别名
——
2-(4-phenylpiperazin-1-ylmethyl)indole-3-carbaldehyde oxime化学式
CAS
459448-42-1
化学式
C20H22N4O
mdl
——
分子量
334.421
InChiKey
CVCVTMULKVMAMX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    2-(4-phenylpiperazin-1-ylmethyl)indole-3-carbaldehyde oxime三乙胺三氟乙酸酐 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 以67%的产率得到2-(4-Phenylpiperazin-1-ylmethyl)-1H-indole-3-carbonitrile
    参考文献:
    名称:
    Phenylpiperazinylmethylindolecarboxylates and derivatives as selective D4-Ligands
    摘要:
    Novel phenylpiperazinylmethylindolecarboxylates were synthesized for evaluation as potential D-4-ligands. Test compounds showed high affinity for the human dopamine D-4 receptor and great selectivity over the other receptor subtypes. Intrinsic effects of indole derivatives, which indicated most promising binding properties, were investigated in a mitogenesis assay. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(02)00042-1
  • 作为产物:
    描述:
    2-(4-Phenylpiperazin-1-ylmethyl)-1H-indole-3-carbaldehyde盐酸羟胺三乙胺 作用下, 以 乙醇 为溶剂, 反应 3.0h, 以63%的产率得到2-(4-phenylpiperazin-1-ylmethyl)indole-3-carbaldehyde oxime
    参考文献:
    名称:
    Phenylpiperazinylmethylindolecarboxylates and derivatives as selective D4-Ligands
    摘要:
    Novel phenylpiperazinylmethylindolecarboxylates were synthesized for evaluation as potential D-4-ligands. Test compounds showed high affinity for the human dopamine D-4 receptor and great selectivity over the other receptor subtypes. Intrinsic effects of indole derivatives, which indicated most promising binding properties, were investigated in a mitogenesis assay. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(02)00042-1
点击查看最新优质反应信息